NCT03297021View on ClinicalTrials.gov

Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting

PHASE4CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

April 5, 2019

Study Completion Date

April 5, 2019

Conditions
Post-operative Nausea and Vomiting
Interventions
DRUG

Ondansetron 4 MG

dose as per arm selection

DRUG

Ondansetron 8mg

dose as per arm selection

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03297021 - Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting | Biotech Hunter | Biotech Hunter